In The News
The FDA just rewrote the rules on HRT
In 2024 the FDA removed the black box warnings from six hormone replacement therapy products — the strongest reversal of menopause guidance in two decades. Those warnings traced back to a 2003 readout of the Women's Health Initiative that grouped older, higher-risk women together with women in their early 50s and labeled the combined risk as "increased breast cancer." A generation of doctors stopped prescribing. A generation of women suffered through hot flashes, bone loss, and sleepless nights they didn't have to.
The updated evidence is clear: women who begin HRT within 10 years of menopause onset show lower all-cause mortality, fewer fractures, better cardiovascular outcomes, and protection against cognitive decline. The conversation is finally catching up to the science.
Why it matters for you: if a doctor dismissed HRT a decade ago, the guidance they used no longer exists. It's worth asking again — armed with a current hormone panel.





